From evidence-based medicine to marketing-based medicine: Evidence from internal industry documents [Book Review]
Journal of Bioethical Inquiry 7 (1):13-29 (2010)
AbstractWhile much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.
Similar books and articles
Clinical Intuition Versus Statistics: Different Modes of Tacit Knowledge in Clinical Epidemiology and Evidence-Based Medicine.Hillel D. Braude - 2009 - Theoretical Medicine and Bioethics 30 (3):181-198.
Clinical Evidence and the Absent Body in Medical Phenomenology.Maya J. Goldenberg - 2010 - International Journal of Feminist Approaches to Bioethiics 3 (1):43-71.
The Virtues of Evidence.Erica Zarkovich & R. E. G. Upshur - 2002 - Theoretical Medicine and Bioethics 23 (4-5):403-412.
Toward Evidence-Based Evidence: Supporting Forensic Knowledge Claims in the Post-Daubert Era.Simon A. Cole - unknown
Iconoclast or Creed? Objectivism, Pragmatism, and the Hierarchy of Evidence.Maya J. Goldenberg - 2009 - Perspectives in Biology and Medicine 52 (2):168-187.
Rational Diagnosis and Treatment: Evidence-Based Clinical Decision-Making.Peter Gøtzsche - 2007 - J. Wiley.
Is There a Tension Between Doctors' Duty of Care and Evidence-Based Medicine?Wendy A. Rogers - 2002 - Health Care Analysis 10 (3):277-287.
The Spatialisation of Disease: Foucualt and Evidence-Based Medicine (Ebm). [REVIEW]Brian Hazelton Walsh - 2010 - Journal of Bioethical Inquiry 7 (1):31-42.
On Evidence and Evidence-Based Medicine: Lessons From the Philosophy of Science.Maya J. Goldenberg - 2006 - Social Science and Medicine 62 (11):2621-2632.
Added to PP
Historical graph of downloads
Citations of this work
Retractions in the Scientific Literature: Is the Incidence of Research Fraud Increasing?R. Grant Steen - 2011 - Journal of Medical Ethics 37 (4):249-253.
“Personal Knowledge” in Medicine and the Epistemic Shortcomings of Scientism.Hugh Marshall McHugh & Simon Thomas Walker - 2015 - Journal of Bioethical Inquiry 12 (4):577-585.
“Snake-Oil,” “Quack Medicine,” and “Industrially Cultured Organisms:” Biovalue and the Commercialization of Human Microbiome Research. [REVIEW]Melody J. Slashinski, Sheryl A. McCurdy, Laura S. Achenbaum, Simon N. Whitney & Amy L. McGuire - 2012 - BMC Medical Ethics 13 (1):28-.
Public Health Autonomy: A Critical Reappraisal.Frederick J. Zimmerman - 2017 - Hastings Center Report 47 (6):38-45.
Letter to the Editor: The Important Distinction Between Ghostwriting and Professional Medical Writing Services.Adam Jacobs - 2010 - Journal of Bioethical Inquiry 7 (3):287-287.
References found in this work
Ghost Management: How Much of the Medical Literature is Shaped Behind the Scenes by the Pharmaceutical Industry?Sergio Sismondo - manuscript
Clinical Trials and Drug Promotion.Jon Jureidini, Leemon McHenry & Peter Mansfield - 2008 - International Journal of Risk and Safety in Medicine 20:73-81.
Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study.Leemon McHenry & Jon Jureidini - 2008 - Accountability in Research 15 (3):152-167.
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib.Joseph Ross, Kevin Hill, David Egilman & Harlan Krumholz - 2008 - Journal of the American Medical Association 299 (15):1800-12.